Cabergoline unveils promising results in treating hyperprolactinemia and Parkinson’s disease.
11/09/2023
with Коментарів немає
Cabergoline is a medication that belongs to the class of dopamine receptor agonists. It is primarily used to treat conditions caused by an excess of the hormone prolactin in the body, also known as hyperprolactinemia. This condition can occur due … Read More
